The Experience and Health-Related Quality of Life after Haploidentical Stem Cell Transplantation for Adults with Sickle Cell Disease

Volume: 41, Issue: 12, Pages: 1829 - 1844
Published: Aug 18, 2019
Abstract
Haploidentical hematopoietic stem cell transplantation (HSCT) from partially matched first-degree relatives (e.g., parent, sibling, child) is the newest therapy available to reverse symptoms of adults with sickle cell disease. Because of this innovation, little is known about the recipients’ transplant experiences and how this type of transplant affects their quality of life. We describe the experiences and health-related quality of life (HRQOL)...
Paper Details
Title
The Experience and Health-Related Quality of Life after Haploidentical Stem Cell Transplantation for Adults with Sickle Cell Disease
Published Date
Aug 18, 2019
Volume
41
Issue
12
Pages
1829 - 1844
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.